Gingko quarterlyTrent Munro — MicrobaSVP Therapeutics“Microba's...

Gingko quarterly

Trent Munro — Microba
SVP Therapeutics
“Microba's project with Ginkgo has really accelerated our
progress in three main ways.
● Ginkgo's extensive large equipment infrastructure has let
us execute custom workflows which would just not be
possible internally, and these cost savings let us deploy
capital in other areas such as clinical development.
● Ginkgo's expertise and resources have moved our
drug discovery project along at a pace that just would
not be possible either using internal resources or via a
traditional CRO approach.
● Project is on track to deliver a very large dataset and
Ginkgo's capabilities allow us to scan a much broader
breadth of the biological design space, with potential to
identify a range of potential leads across our focus
therapeutic areas.”
T